Merck to Divest CDMO Business to Lonza
Merck Group has announced its decision to divest its Contract Development and Manufacturing Organization (CDMO) business to Lonza. This strategic move will transfer Merck's CDMO operations to Lonza, a global leader in life sciences, aiming to enhance focus on core activities and streamline business operations.
Merck Group·



